Patents Assigned to CRISPR Therapeuticas AG
  • Publication number: 20190330604
    Abstract: The present disclosure provides materials and methods for treating a patient with one or more conditions associated with SOD1 whether ex vivo or in vivo. In addition, the present disclosure provides materials and methods for editing and/or modulating the expression of SOD1 gene in a cell by genome editing.
    Type: Application
    Filed: June 15, 2017
    Publication date: October 31, 2019
    Applicant: CRISPR Therapeuticas AG
    Inventors: Ante Sven LUNDBERG, Samarth KULKARNI, Lawrence KLEIN, Hari Kumar PADMANABHAN